(Q36746882)

English

Clinical phase 1 testing of the safety and immunogenicity of an epitope-based DNA vaccine in human immunodeficiency virus type 1-infected subjects receiving highly active antiretroviral therapy

research work

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Clinical phase 1 testing of the safety and immunogenicity of an epitope-based DNA vaccine in human immunodeficiency virus type 1-infected subjects receiving highly active antiretroviral therapy (English)

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

anti-retroviral agent

0 references

Robert T. Schooley

7

object named as

Robert T Schooley

Schooley, R. T.

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Samantha Mawhinney

4

object named as

Samantha MaWhinney

MaWhinney, S.

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

author name string

Cara C Wilson

1

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Mark J Newman

2

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Brian D Livingston

3

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Jeri E Forster

5

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Jim Scott

6

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Constance A Benson

8

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Newman, M. J.

2

0 references

Wilson, C. C.

1

0 references

Livingston, B. D.

3

0 references

Forster, J.E.

5

0 references

Scott, J.

6

0 references

Benson, C.A

8

0 references

publication date

9 April 2008

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

2008

0 references

Clinical and Vaccine Immunology

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

15

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

6

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

986-994

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

http://ugspace.ug.edu.gh/handle/123456789/837

0 references

Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell induction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446619

29 September 2017

Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446619

29 September 2017

Expansion and diversification of virus-specific T cells following immunization of human immunodeficiency virus type 1 (HIV-1)-infected individuals with a recombinant modified vaccinia virus Ankara/HIV-1 Gag vaccine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446619

29 September 2017

Relative dominance of Gag p24-specific cytotoxic T lymphocytes is associated with human immunodeficiency virus control

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446619

29 September 2017

HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446619

29 September 2017

HLA-B63 presents HLA-B57/B58-restricted cytotoxic T-lymphocyte epitopes and is associated with low human immunodeficiency virus load

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446619

29 September 2017

DNA vaccines against human immunodeficiency virus type 1 in the past decade

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446619

29 September 2017

Development of a DNA Vaccine Designed to Induce Cytotoxic T Lymphocyte Responses to Multiple Conserved Epitopes in HIV-1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446619

29 September 2017

Safety and immunogenicity of ALVAC vCP1452 and recombinant gp160 in newly human immunodeficiency virus type 1-infected patients treated with prolonged highly active antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446619

29 September 2017

Identification of novel HLA-A2-restricted human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte epitopes predicted by the HLA-A2 supertype peptide-binding motif

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446619

29 September 2017

Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446619

29 September 2017

Factors that predict incomplete virological response to protease inhibitor-based antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446619

29 September 2017

Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446619

29 September 2017

Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446619

29 September 2017

Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446619

28 June 2018

Safety and immunogenicity of cytotoxic T-lymphocyte poly-epitope, DNA plasmid (EP HIV-1090) vaccine in healthy, human immunodeficiency virus type 1 (HIV-1)-uninfected adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446619

5 September 2018

Transience of vaccine-induced HIV-1-specific CTL and definition of vaccine "response".

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446619

5 September 2018

Plasmid vaccination of stable HIV-positive subjects on antiviral treatment results in enhanced CD8 T-cell immunity and increased control of viral "blips".

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446619

5 September 2018

Immunological and virological efficacy of a therapeutic immunization combined with interleukin-2 in chronically HIV-1 infected patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446619

5 September 2018

A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446619

5 September 2018

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446619

5 September 2018

Studies in subjects with long-term nonprogressive human immunodeficiency virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2446619

5 September 2018

Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/18400976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diverse repertoire of HIV-1 p24-specific, IFN-gamma-producing CD4+ T cell clones following immune reconstitution on highly active antiretroviral therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18400976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic vaccination with MVA-HIV-1 nef elicits Nef-specific T-helper cell responses in chronically HIV-1 infected individuals

1 reference

https://pubmed.ncbi.nlm.nih.gov/18400976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recognition of variant HIV-1 epitopes from diverse viral subtypes by vaccine-induced CTL

1 reference

https://pubmed.ncbi.nlm.nih.gov/18400976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic vaccination of HIV-1-infected patients on HAART with a recombinant HIV-1 nef-expressing MVA: safety, immunogenicity and influence on viral load during treatment interruption

1 reference

https://pubmed.ncbi.nlm.nih.gov/18400976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic immunization of highly active antiretroviral therapy-treated HIV-1-infected patients: safety and immunogenicity of an HIV-1 gag/poly-epitope DNA vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/18400976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sustained control of viremia following therapeutic immunization in chronically HIV-1-infected individuals

1 reference

https://pubmed.ncbi.nlm.nih.gov/18400976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of HIV vaccine-induced cell-mediated immunity in HIV-seronegative clinical trial participants using an optimized and validated enzyme-linked immunospot assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/18400976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/18400976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infectious history

1 reference

https://pubmed.ncbi.nlm.nih.gov/18400976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/CVI.00492-07

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

University of Ghana Digital Collections (UGSpace) ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36746882&oldid=1945315068"